Advice
In the absence of a submission from the holder of the marketing authorisation
choriogonadotropin (Ovitrelle) is not recommended for use within NHS Scotland for women undergoing superovulation prior to assisted reproductive techniques such as in vitro fertilisation (IVF).
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHS Scotland.
Download detailed advice28KB (PDF)
Medicine details
- Medicine name:
- choriogonadotropin alfa (Ovitrelle)
- SMC ID:
- 263/06
- Indication:
- Superovulation prior to assisted reproductive techniques such as in vitro fertilisation (IVF)
- Pharmaceutical company
- Serono Ltd
- BNF chapter
- Endocrine system
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 08 May 2006